An efficient and novel synthesis of (R)-rugulactone has been achieved employing Sharpless asymmetric epoxidation of allyl alcohols followed by selective hydride reduction of epoxy alcohols and olefin cross metathesis reactions.
Introduction
The 6-alkyl and aryl substituted -pyrones (6-arylalkyl-5,6-dihydro-2H-pyran-2-ones) possess important biological properties such as antitumor, antiviral, antifungal, and antiinflammatory [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . These properties arise as a result of Michael acceptor property of -pyrones towards the amino acid residues of the receptors. The biological assays of 6-arylalkyl-5,6-dihydro-2H-pyran-2-one, (R)-rugulactone (1), which has been extracted from the evergreen tree Cryptocarya rugulosa [13] of Lauraceae family, have been found to inhibit the nuclear factor (NF-B) activation pathway occurring in different types of cancers [14] [15] [16] [17] [18] . Due to the attractive biological activity of (R)-rugulactone (1) (Figure 1 ), several total syntheses have already been reported in the literature [19] [20] [21] [22] [23] [24] [25] . In those reported syntheses the chiral center was created by different means: by Jacobsen's hydrolytic kinetic resolution of epoxides [19] , by Keck's asymmetric allylation [21] , by proline catalyzed -aminoxylation [22] of aldehydes, by enzymatic resolution of racemic homoallylic alcohols [23] , and by using a chiral pool [24, 25] . In this communication, we describe the stereoselective synthesis of (R)-rugulactone starting from inexpensive starting materials. The Sharpless asymmetric epoxidation of allyl alcohols followed by selective hydride reduction affords 1, 3-diols with high stereoselectivity. These chiral 1, 3-diols are versatile synthetic intermediates for a variety of biologically active molecules [26] [27] [28] . The retrosynthetic strategy of our synthesis is depicted in Scheme 1, which involves Grubb's cross metathesis between compounds 11 and 12. 4 (0.23 g, 0.8 mmol) were added sequentially to a suspension of 4Å molecular sieves (3 g) in CH 2 Cl 2 (20 mL) at −20 ∘ C and the suspension was stirred for 30 min. A solution of compound 3 (0.6 g, 2.6 mmol) in dry CH 2 Cl 2 (15 mL) was then added dropwise at the same temperature followed by the addition of tBuOOH (0.45 g, 2 mmol) and the reaction mixture was stirred for 12 h at −10 ∘ C. When the starting material was not observed on the TLC, the reaction was quenched with 20% NaOH solution saturated with NaCl (1 mL) and the reaction mixture was stirred vigorously for another 30 min at RT. The resulting reaction mixture was filtered through Celite, the solvent was evaporated, and the crude product was purified by column chromatography over silica gel (60-120 mesh, EtOAc/hexane 3 : 7) to afford pure epoxy alcohol 4 in 87% yield (0. 
Materials and Methods

(R)-5-(Benzyloxy)pentane-1,3-diol, 5.
To a stirred solutionof epoxy alcohol (0.15 g, 0.75 mmol) in THF (5 mL) at −15 ∘ C dropwise solution of sodium bis(methoxyethoxy)aluminum hydride (Red-al) (3.5 M solution in toluene, 1.2 mmol) was added. The reaction mixture was stirred for 6 h at the same temperature. When no starting material was observed on TLC, the temperature was raised to 0 ∘ C, reaction mixture was quenched with citric acid solution, and the resultant reaction mixture was stirred for another 10 min. Then contents were decanted leaving behind a residue, which was further dissolved in water and extracted with EtOAc thrice. The combined organic layers were evaporated under reduced pressure, and the residue was chromatographed over silica gel (60-120 mesh, EtOAc/hexane 3 : 7) yielding pure diol (0. 14 
(R,E)-6-(4-Oxo-6-phenylhex-2-enyl)-5,6-dihydro-2H-pyran-2-one(R)-
(i) DMSO, (COCl) 2 , Et 3 N, CH 2 Cl 2 , −78 ∘ C, 1 h. (ii) EtO 2 CCH 2 P(O)(OCH 2 CF 3 ) 2 , NaH, dry THF, −78 ∘ C, 2 h, 74%. (h) CSA, MeOH:CH 2 Cl 2 (1 : 1), RT, 85%. (i) DMSO, (COCl) 2 , Et 3 N, CH 2 Cl 2 , −78 ∘ C, 1 h. (ii) (C 6 H 5 ) 3 PCH 3 I, n-BuLi, THF, 0 ∘ C, 82%. (j) PTSA, MeOH, 3 h, 91%. O O O O O O + (a) [16]
Results and Discussion
As outlined in Scheme 2, our synthetic strategy commenced with 3-benzyloxypropanol. The primary alcohol of 3-benzyloxypropanol was oxidized by using Swern's protocol to the corresponding aldehyde, and then Horner-WadsworthEmmons olefination of aldehyde afforded , -unsaturated ester 2 in 95% yield. The compound 2 was subsequently reduced to allyl alcohol 3 by employing alane reduction (LiCl/LiAlH 4 ) conditions [29] . The allyl alcohol 3 was then subjected to Sharpless asymmetric epoxidation [30, 31] to produce epoxy alcohol 4 in 85% yield, whichon selective hydride reduction with Red-al [32, 33] yielded 1, 3-diol 5. The two hydroxyl groups in 5 were completely protected from its disilyl ether 6. The subsequent removal of benzyl group was achieved by using Birch debenzylation [34] protocol to afford alcohol 7, which was further oxidized to aldehyde and StillGennari modification of Horner-Emmons [35] olefination of the crude aldehyde produced Z/E 95 : 5 mixture of , -unsaturated ethyl esters in favor of desired isomer 8. The geometric isomers were easily separated using silica gel column chromatography to get pure Z isomer of ethyl ester in 74% yield. Later the primary silyl ether was selectively cleaved to produce alcohol 9, which on further oxidation followed by Wittig olefination furnished unsaturated ester 10. Further , -unsaturated ester 10 was stirred in methanol for 2 h in presence of p-toluene sulfonic acid to furnish 11 in 91% yield.
The remaining task was to couple the fragment 5-phenylpent-1-en-3-one [36] 12 and lactone 11 (3 : 1 ratio) by cross metathesis [37] [38] [39] , which was implemented by refluxing them in CH 2 Cl 2 in presence of Grubb's second generation catalyst [40] 
Conclusions
The stereoselective total synthesis of naturally occurring bioactive compound (R)-rugulactone has been successfully achieved employing Sharpless asymmetric epoxidation of allyl alcohol, selective hydride reduction of epoxy alcohol, and olefin cross metathesis reactions as the key steps. The synthetic route can conveniently be utilized for the preparation of various analogs of (R)-rugulactone useful for biological evaluation.
